We describe recent progress in parallel molecular genetic analyses using DNA microarrays, gel-based systems, and capillary electrophoresis and utilization of these approaches in a variety of molecular biology assays. These applications include use of polymorphic markers for mapping of genes and disease-associated loci and carrier detection for genetic diseases. Application of these technologies in molecular diagnostics as well as fluorescent technologies in DNA analysis using immobilized oligonucleotide arrays on silicon or glass microchips are discussed. The array-based assays include sequencing by hybridization, cDNA expression profiling, comparative genome hybridization and genetic linkage analysis. Developments in non microarraybased, parallel analyses of mutations and gene expression profiles are reviewed. The promise of and recent progress in capillary array electrophoresis for parallel DNA sequence analysis and genotyping is summarized. Finally, a framework for decision making in selecting available technology options for specific molecular genetic analyses is presented.
Introduction
Progress from the Human Genome Initiative and related efforts will soon result in the generation of the sequence of all expressed human genes and the identity of many more disease-causing or disease-predisposing mutations. Knowledge of genomes of multiple other eukaryotic and prokaryotic organisms has progressed as well. Increasing attention has been devoted to parallel molecular genetic analysis methods in order to facilitate the search for multiple genetic alterations at the same time and to advance functional genomics (assessment of gene expression in specific tissues, during development, or in disease states). This review summarizes recent developments in parallel molecular genetic analysis of interest to human genetics.
Functional genomics studies increasingly necessitate obtaining the results of multiple molecular genetic analyses at the same time. For example, genes which cause human diseases may contain many different mutations linked to the phenotype, and efficient strategies to scan for these mutations are needed. Furthermore, thousands of genes are expressed in any given cell. Differences in gene expression between cells accompany both normal development and development of the malignant cell phenotype. Methods for rapid identification of differentially expressed genes will lead to increased understanding of cell development and perhaps better therapy for cancer. Parallel molecular genetic analysis provides simultaneous information about many genes. Parallel analyses can also provide large amounts of information from small amounts of starting cellular material. The concept of parallel is distinct from but related to that of high throughput, which results in the generation of large amounts of molecular genetic information per unit time. It is possible to have a parallel process which is not high throughput if it takes a long time to obtain information about multiple genes. Conversely, most high-throughput processes are parallel, because serial molecular genetic analyses will tend to increase the overall time needed. Methods in which multiple wet biochemical steps within a single tube or microwell for each molecular analysis are followed by gel electrophoresis of radiolabeled products and then development of a gel image by autoradiography have been standard in molecular genetic analysis, but such methods are intrinsically low throughput. In this review we examine several methods of parallel molecular genetic analysis which are of increasing importance in a number of fields. [1] [2] [3] [4] [5] DNA microarrays, capillary array electrophoresis, mass spectrometry, homogeneous solution assays and hybrids of these methods are all particularly promising technologies.
We begin with DNA microarrays with their myriad uses, then move to parallel mutation detection methods and gene expression profiling methods that do not use microarrays, and finally capillary array electrophoresis approaches to DNA sequence analysis and microsatellite-based genotype analysis. Generalizable highthroughput analytic approaches accessible to any laboratory with molecular genetics expertise will be highlighted. Areas which will not be discussed and for which the reader is directed to recent reviews or references include gene expression profiling in situ, 6 protein expression profiling using 2D gels and mass spectrometry analysis, 7-9 parallel cellular and nucleic acid sample preparation, [10] [11] [12] and bio-informatics approaches to data processing and interpretation. [13] [14] [15] 
DNA Microarrays
DNA microarrays have been variously called DNA chips and DNA biochips. The common denominator is a solid platform with a set of immobilized nucleic acid species that participates in a solid-fluid interfacial interaction with a solution of complementary nucleic acid targets. Uses of the DNA microarray include mutation and polymorphism detection, definition of gene expression profiles, genotyping, defining gene organization and mapping, and DNA sequence analysis of previously uncharacterized regions, among others. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] Since a high density of genes can be studied in parallel, only a small amount of sample is needed. This technology is mostly robotic driven; consequently it can easily be introduced into many research and clinical laboratories.
Mutation and Polymorphism Detection
Microchips consisting of ordered arrays of oligonucleotide probes have been applied to hybridization-based mutation detection schemes. This approach represents in some sense a miniaturization of the use of immobilized oligonucleotides in 96 well plates with several important technical and conceptual differences. With glass or silicon chips, a high degree of parallel array formation increases the information content. With a high number of closely related oligos on a surface, information about partial matches may also be obtained when perfect match duplex values are obtained with fluorescence. Furthermore, the PCR step which is often used to generate reagents for annealing to immobilized probes can now be done in a silicon chip microenvironment. [40] [41] [42] The DNA microarray technique has been used to analyze the entire human mitochondrial DNA, 24 to detect polymorphisms in the HIV-1 clade B protease gene, 25 and to detect mutations in BRCA1, 26, 36 the cystic fibrosis transmembrane receptor gene and p53. 23, 34 In an extension of DNA microarray technology, Pastinen and colleagues reported allele-specific detection of 12 common disease-causing mutations in the Finnish population using a microarray and singlenucleotide extension. 43 Detection of beta-globin gene alleles and mutations has also been reported by several groups. 28, 44, 45 
Gene Expression Profiling
The potential for this type of gene expression chip is enormous. There are at least three things one wants to know about an mRNA in a cell. Is it present or absent? What is its quantitative level of abundance? What difference is there in this level between two different cellular samples? Parallel mRNA expression monitoring by DNA microarray methods has been reported by several different groups with different approaches. Two papers in the peer-reviewed literature summarize the Affymetrix experience in the gene expression area. 46, 47 The work demonstrates detection of transcripts at the 1 in 300 000 level, equivalent to 1 copy per cell, with a dynamic range between 1000 and 10 000. Fragmented RNA target preparation appears advantageous kinetically, in that information was available with hybridization times as short as 2 hours. For the less abundant transcripts, hybridization up to 20 hours was employed. There is a very high degree of probe redundancy (20 to 300 probe pairs per target) and high complexity in the computational analysis, both of which may relate to the fact that light-directed in situ synthesis currently yields only 3 to 5% of full-length, correct probe sequence per spot for a 20 mer. They have not reported explicit comparison with alternative probes, such as cDNA fragments or presynthesized oligonucleotides. The generalizability of the method to any laboratory with molecular genetics expertise is limited by the need for photolithography, and adaptability for newly discovered targets is potentially slow and costly since new masks might need to be made.
The Stanford/Synteni groups have published several papers using cDNA arrays to assess gene expression, first in yeast and plants and then in human cells. [48] [49] [50] [51] The two-color approach directly provides information comparing two cellular inputs. The cDNA microarrays are very specific and their array methodologies are adaptable by others [www.cmgm.stanford.edu/pbrown]. Alterations in a number of interesting genes in cellular pathways in response to extracellular perturbations have been identified. With cDNA probes, the kinetics of hybridization is relatively slow and the detection of low copy number transcripts, which account for the majority of the transcripts in a cell by number, is unclear. The reports cite 1 in 10 000 detected on a per mass basis, and one report indicates a 1 in 100 000 detection sensitivity on a per mass basis. With a cDNA microarray, splice variants and closely related gene family members may not be distinguished.
Workers at Molecular Dynamics reported gene expression results with their arrayer and scanner at the Hilton Head '97 meeting [www.mdyn.com/posters/hiltonhead97]. In bacterial systems, 2 to 3-fold differences in expression of transcripts at abundance levels as low as 1:300 000 were reliably detected. Custom arraying by the end user, after an initial investment, may meet the needs of many research laboratories. The Molecular Dynamics scanner employs confocal microscopy and a photomultiplier tube and is sensitive to 0.1 attomole of fluorescent dye per square micron. 52 For microarray methods for mRNA detection and quantitation, gene discovery efforts may benefit from arraying probes for potentially all the expressed genes in the human genome. Even before the whole human genome is sequenced, the huge repertoire of expressed sequence tagged sites (ESTs) can be arrayed and studied. 48, 53 Such a chip can be used to study gene expression during development, disease states and in normal metabolic homeostasis. Later, disease-targeted, user-adaptable arrays with probes for several hundred targets may be most useful in the clinical and biological research laboratories.
Other Anticipated Uses of DNA Microarrays
These include genetic linkage, forensic identification, pathogen identification, sequence analysis by hybridization of previously uncharacterized regions and comparative genome hybridization. [54] [55] [56] [57] In addition, SingleNucleotide Polymorphism (SNP)-based tests are adaptable to the microarray. The use of Southern blotting and detection of restriction fragment length polymorphism (RFLP) markers provided an initial relatively low resolution human genetic map for linkage analysis. These markers have largely been replaced by simple sequence repeat or microsatellite markers which are both simpler to run and are more highly polymorphic (more informative so fewer markers must be run to derive the same degree of confidence of linkage in gene discovery studies). The microsatellite map in human genetics is now quite dense, for example, Dibs 58 recently published the primer sequence and allele size ranges of 5264 microsatellite markers. Consequently, microsatellite genotyping has quickly become adopted in linkage analysis, disease association studies, and in the study of altered profiles diagnostic of certain cancers (evidence of loss of heterozygosity (LOH) or microsatellite instability (MSI). Thus, the microsatellite markers are the current method of choice for many molecular genetic research projects and provide the basis of a much more dense and powerful 'second generation' genetic map. However, microsatellite typing generally requires electrophoretic separation of the PCR-amplified markers in very high-resolution gels, a labor intensive and time-consuming process when slabgel electrophoresis systems are used. Consequently, so-called 'third generation' marker sets are under development at several genomic research institutes including the Whitehead Institute (Boston, MA) and GenSet (Paris, France).
The third-generation markers are single-nucleotide polymorphisms (SNP). SNP markers are fundamentally the same as the RFLP markers (base substitutions) but with improvements in detection methods, and are now identified and screened without the use of electrophoresis or Southern blotting. SNP markers can be detected in microplate or microarray-based formats. The inherent variability within the human genome results in base substitutions at approximately 1 kb intervals. When alternative alleles (base substitutions) have reached a frequency of 30% or greater, they can be very useful in genetic analysis. With the very high density of these markers in the genome, it is possible to determine regional haplotypes (ordered alleles that cosegregate along a common stretch of chromosome). Haplotype mapping helps compensate for the lower informativeness of each SNP marker relative to the microsatellite markers. Nevertheless, it is estimated that a 4-cM map of 750 SNP markers will be required to provide the same degree of genetic information as a 10-cM map of approximately 300 microsatellite markers. 56 The primary motivation for developing a third generation map is that the SNP markers are much more amenable to automation and detection on array-based systems. For example, the Whitehead Institute, Millennium and Affymetrix have an active program identifying and mapping SNP markers using genomic clones which are physically mapped. Similarly, GenSet in collaboration with Abbott Laboratories also have an SNP marker development program with the goal of identifying up to 30 000 SNP markers in the human genome by the end of 1999.
A set of SNP markers uniformly distributed across the genome would have additional applications besides linkage analysis. For example, the use of a 10 000 SNP marker set would permit a genome-wide scan for loss of heterozygosity (LOH) at a resolution of under 1 Mbase (average spacing of the SNP markers would be 300 000 nucleotides). This would be a higher resolution LOH scan than is currently possible using comparative genome hybridization (CGH) carried out using cytogenetic approaches. 57 By strategically positioning the SNP markers to deletion prone regions of the genome and/ or to known locations of oncogenes, the utility of this approach to LOH scanning could be further improved. Tightly clustered SNP markers within large genes that lead to rare genetic disorders would provide an alternative method for a linkage-based strategy for disease diagnostics particularly in new mutation disorders (each family has a unique, uncharacterized mutation). For example, the dystrophin gene is approximately 2.4 Mbase in size and five microsatellite markers are used to follow intragenic recombination in families where either Duchenne or Becker muscular dystrophy are segregating and the responsible mutation fails to be detected using standard exon-screening tests. [59] [60] [61] Approximately 24 polymorphic SNP markers would be expected to be found within the dystrophin gene. These would naturally have tighter spacing than the current set of intragenic microsatellite markers. By scoring the alleles at the SNP markers, the haplotype of the disease-carrying allele could be identified. A linkage-based method of diagnosis may prove more reliable than a mutation screening-based method in the difficult case of accurately providing diagnosis when the disease-causing gene is very large. Similarly, complex disorders which have multiple genes involved might permit rapid diagnosis using a linkage-based approach. For example, it is estimated that there are 50 genes responsible for inherited deafness. By haplotyping in the vicinity of known genes that could contribute to this disorder, fewer family members might be required to identify which gene is involved for any one family.
Research and Development Issues in DNA Microarrays
Research and development issues in DNA microarrays that operate by hybridization have been the probes (the immobilized species), the targets (the solution-phase reverse complements of the surface probes), the surfaces, the detection labels, the hybridization conditions, and the detection principle. To our knowledge, 12 separate groups worldwide including our own to date have published the operating details of their microarrays. Probes are obtained by synthesis in situ or deposition of pre-synthesized molecules. Two main types of synthesis in situ have been described: lightbased combinatorial 16, 62 or physical combination.
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Deposition of pre-synthesized oligonucleotides, 20, 44, 64, 65 cDNAs [48] [49] [50] [51] or nucleic acids with other base and backbone modifications such as PNAs [66] [67] [68] have been reported. Oligonucleotide probes appear to benefit from spacer arms that link the nucleic acids to the surface. 20, 44, 69 Targets have been single-or doublestranded DNA or RNA. A few investigators have explicitly examined varied hybridization conditions. 70, 71 A variety of surfaces have been described, ranging from glass to silicon to plastic to paper to silanized glass. 16, 20, 44, 72, 73 There is a multitude of detection labels, radioactive and light-based. Advantages accrue to the use of light-based detection labels. Detection labels have been based on fluorescence or chemiluminescence, and both primary (label on the target) and secondary (label on a molecule which binds a group on the target or duplex) detection are in use. 74 Detection devices include the proximal CCD, 64, 75 CCD-microscope, 30, 44 and PMT-confocal microscope [21] [22] [23] [24] [25] [26] systems. Discriminating single-base mutations from normals and especially heterozygotes is fraught with difficulties. We and others have seen unexpected and largely unexplainable hybridization patterns when a given target is hybridized to a series of probes with overlapping sequences. 44, 76, 77 Many examples have concentrated on the difficulties of detecting point mutations. However, similar statements could be made about present techniques for quantitating other important molecular genetic features, such as the absolute expression levels of particular mRNAs. In each case, hybridization alone, while powerful, is unlikely to be capable of providing a complete and unambiguous answer. We and others are turning to combined hybridization and reaction in situ: single-nucleotide extension (SNE), 43, 78 PCR in situ, [79] [80] [81] reporter/quencher uncoupling chemistry (R/Q), 82 and ligase chain reaction (LCR) 83 among others. We designate microarrays that operate by hybridization that follows diffusion of targets to their cognate probes as first generation DNA microarrays. Second generation microarrays have one or more of the following features: active capture of targets, eg by electric field, and hybridization coupled to reaction. There has been a lot of empiricism, but also a considerable contribution to microarray design by fundamental studies. 35, 44, 45, 69, 72, 73, 76, [84] [85] [86] [87] The capture rate of a nucleic acid in solution, J (moles/cm 2 ), by its reverse complement immobilized on a solid surface, when the number of surface 'probe' molecules is in molar excess, is given by: 84, 85 J = (πγD 3 /4H)C 0 t Molecular biologists with experience in solutionphase hybridization studies understand the dependence on C 0 t. This theoretical result places physical observables in the factors other than C 0 t which determine capture and hybrid formation specifically at the solidliquid interface. This J is the initial rate -eventually the capture saturates at an inverse exponential rate, but most detection can and does operate before that point is reached. The parameter γ incorporates all of the 3-and 2-dimensional diffusion effects, adsorption at the surface, probe density within a site, probe molecular length and target length. D 3 is the solution diffusion coefficient of the target. The smaller the target, the larger is D 3 and the more rapid its capture by the diffusive mechanism, supporting the empirical practice of fragmenting into smaller targets. [21] [22] [23] [24] [25] [26] Fragmentation also minimizes secondary structure, an effect discussed later. H is the boundary layer, often in the length scale of tens of microns, over which the concentration changes from its bulk solution value to that right at the interface. Decreasing H, for example by stirring or by 'excluding volume' from the bulk solution with amphipathic organic molecules like PEG or phenol increases capture. 44, 86, 88 If a second mechanism of capture at the surface is included, like electric field, capture can be enhanced. This underlies another published approach, which is very rapid but employs more complex chip manufacture and operation. 70 The side-on orientation of DNA molecules on common silanized surfaces has been observed experimentally. 87 Further progress in rational design from biophysical and biochemical fundamental study is anticipated.
Non Microarray-based Parallel Mutation Detection Methods
DNA sequence variation detection methods share several conceptual issues, such as whether a known change is being detected or a region is being scanned for new mutations, whether the end user of the method is a clinical laboratory or a research laboratory, whether the change to be identified is a disease-causing mutation or a polymorphism, and whether the cellular sample is homozygous, hemizygous or heterozygous for the change.
A wide variety of PCR-based mutation detection methods have been described. 89, 90 In general the mutation detection methods can be grouped according to whether they are scanning or allele specific. Within the scanning methods, they can be grouped according to which principle of operation they employ. Wellknown applications for mutation screening include direct DNA sequence analysis, denaturing-gradient gel electrophoresis (DGGE), 91 single-stranded conformation polymorphism (SSCP) 92 and its variants dideoxyfingerprinting (ddF) 93 and restriction endonuclease fingerprinting, 94 heteroduplex analysis including chemical cleavage of mismatches (CCM) 95 and endonuclease 96 and RNase A cleavage. 97 Automated fluorescence-based DNA sequence analysis can generate 600 to 800 nucleotides of sequence data per reaction, and in some sense is parallel in that multiple gel electrophoresis lanes can be analyzed at the same time, as is true for SSCP, DGGE and some of the other methods. Allele-specific mutation/polymorphism detection methods include direct DNA sequence analysis, 98 reverse dot-blot with allele-specific oligonucleotide hybridization, 99 allele-specific PCR amplification, 100 oligonucleotide ligation amplification (OLA), 101 artificial introduction of restriction sites, 102 ligase chain reaction 103 and DNA minisequence analysis. [104] [105] [106] PCR-OLA has been applied to DNA diagnostics, 107 genetic mapping using biallelic markers 108 and YAC library screening. 109 A variation on PCR-OLA to increase sample throughput makes use of sequencecoded separation. 101 Fluorescence-based DNA minisequence analysis facilitates detection of mutated sequences. 110, 111 Limited primer-extension techniques, primer-guided nucleotide incorporation, single-nucleotide primer extension (SNPE) or solid-phase minisequencing were developed previously to detect point mutations by single-base extension of the primer at the site of the mutation. [104] [105] [106] These procedures use a primer designed to hybridize just 5' of the nucleotide to be tested. The primer is extended by a single dyelabeled dideoxynucleotide, thereby indicating the identity of the target nucleotide in the template. Fluorescent extension products are then detected following electrophoresis on denaturing polyacrylamide gels. Fluorescence analysis of the incorporated dye tag reveals the identity of the template nucleotide immediately 3' to the primer site. There are recent examples of the application of the single nucleotide extension principle to the microarray format. 43, 78 Two newer methods are cleavase fragment length polymorphism (CFLP) and multiplex allele-specific diagnostic assay (MASDA). CFLP is a scanning methodology, while MASDA is an allele-specific methodology. CFLP is in the general category of secondary structure-specific mutation detection. Whilst SSCP reflects structure-specific mobilities, CFLP reflects structure-specific nuclease cleavage. 112 MASDA is a multistep process in which multiplex gene-specific PCR is followed by a forward dot-blot using a pool of radiolabeled ASO probes. 113 After the dot-blot, verification of which oligo in the pool hybridized to an array spot is performed by a biochemical fingerprinting assay.
To compare and contrast all of these methods with DNA microarray methods of mutation detection, it is clear that many non microarray methods are up and running now while DNA microarray methods have just passed proof-of-principle and are undergoing initial dissemination. (CE/CAE are discussed below.) Automated fluorescence-based DNA sequence analysis continues to have many desirable features. Gel-based methods that use multicolor fluorescence consolidate separation with detection and have the advantage that software analysis can be built in. The special conditions required for running assays such as DGGE and SSCP have made their implementation on machines designed originally for automated DNA sequencing more problematic. The absence of a cooling unit on these sequencers originally required SSCP gels to be run for long times at very low current to avoid denaturing the annealed species, 114 although other investigators have made modifications to their machines to provide refrigeration capabilities and permit shorter run times. 115, 116 Some technical modifications were also necessary to reduce background problems in the implementation of the fluorescent versions of the CCM 117 and dideoxyfingerprinting assay. 118 Most recent versions of automated sequencers including capillary array electrophoresis equipment (CAE) have built-in temperature control, which permits SSCP and other temperature-dependent applications to be accomplished. Many of these assays can be done using fluorescently-labeled reactions and appropriate detection systems, resulting in automated data collection and semi-automated analysis. 119 In most cases, the use of fluorescence in these assays is limited only by the ability to label the species in an efficient manner without causing background problems. 120 How robust each of these methods are (accuracy, reproducibility and reliability) is of concern to end-users and has limited the acceptance of any one scanning or allele-specific method in molecular genetics laboratories. Microarrays have the inherent advantage that they can do both scanning and allele-specific mutation detection while consolidating the reaction step with detection, thus skipping a distinct separation step. Since physical localization is intrinsic to a spatially addressable array, there is no electrophoretic separation. Currently, microarrays avoid radioactivity and are readily operated with multicolor detection, which increases the amount of information per spot and per unit time. One major distinction between mutation detection methods in the future may be microarrays vs homogeneous Parallel Molecular Genetic Analysis t solution arrays that perform consolidated reaction and detection with no separation step (for example, 'molecular beacon'/Reporter-Quencher systems). 38, 82, 121 Since these homogeneous assays are still under development, how parallel, small and fast these are in comparison to microarrays remain to be determined. Mass spectrometry-based methods have also been proposed and are under development.
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Non Microarray-based Parallel Gene Expression Profiling
Analysis of mRNA, in particular differences in expression patterns between cell types, is an area of intense interest. At this time this is almost exclusively a research laboratory enterprise, not one for the clinical molecular diagnostics laboratory. Several common methods of RNA analysis are not inherently designed as parallel molecular genetic assays, such as northern blot analysis, nuclease protection assays and RT-PCR. Beyond the DNA microarray work described in the preceding section, there are a number of parallel gene expression profiling methods in use in many laboratories. These include Subtractive hybridization (SH), differential display, differential screening, large-scale sequencing and RDA have been in the literature for several years, reviewed recently and are in use in many laboratories. Recent variations of these methods to improve their performance have been described. Improvements in subtractive hybridization may come from positive selection and so-called suppressive hybridization methods. 123 Elements of suppressive hybridization have also been combined recently with elements of differential screening. A variant of differential display PCR has been published recently called ordered dd-PCR. 124 Normalized or self-subtracted libraries appear to enhance performance in large scale DNA sequencing. 122 In commercial research labs, large-scale cDNA sequencing has been reported to identify many novel cDNAs. Much has been learned from the SAGE method. [125] [126] [127] SAGE works by cloning and sequencing strings of 9 to 11 bp fragments from cDNA libraries, and uses statistical sequence analysis first to assign the fragments uniquely to transcripts and then to calculate abundance. Many of the findings from classic hybridization studies in the 1970s concerning the number and abundance classes of mRNAs in cells have been confirmed; 122, 128 86% of transcripts by number are present at less than 5 copies per cell. Of the approximately 15 000 distinct transcripts in a cell, 1-2% differ in cells of closely related origins. If cells of more disparate origins are compared, the percentage of differentially expressed transcripts may rise to 3-5%. Differentially expressed transcripts occur in all abundance classes. SAGE is unfortunately not high throughput and thus is not amenable to the clinical laboratory.
Capillary Array Electrophoresis Methods for DNA Sequence Analysis and Microsatellite Genotype Analysis
Recently, fluorescence detection systems have been coupled with the speed and convenience of capillary electrophoresis (CE) systems which have potential for rapid, high-throughput genetic analysis without the constraints and disadvantages of slab-gel based systems. These systems have already been used to analyze fluorescent sequencing reactions and a variety of dyelabeled fragments. 129, 130 Multiple arrays of capillaries and advances in separation matrices will further enhance resolution, sample throughput and decrease run times. Capillary technology also has the potential to be engineered on a microchip scale, decreasing electrophoresis times by an order of magnitude. [131] [132] [133] Mathies and co-workers developed a laser-excited, confocal fluorescence imaging system for DNA sequencing or mapping fragments in a planar array of several capillaries simultaneously, a technology known as capillary array electrophoresis (CAE). 134, 135 CAE offers an excellent opportunity to develop instrumentation capable of striking increases in efficiency and convenience for DNA analysis. Molecular Dynamics, extending the work in CAE, is developing instrument 136, 137 This could increase throughput of fluorescence DNA sequencing and mapping by over an order of magnitude.
Labor-intensive steps of fragment separations are eliminated by CAE. Slab gel preparation is replaced by automated capillary filling using a low-viscosity gel matrix, refillable capillaries and a pressurized gel-filling station. 138 The process is complete within 10 minutes without user intervention. Gel loading, another tedious, labor-intensive step, is replaced with electrokinetic injection of 48-96 samples at a time. Capillaries are then purged and refilled using the gel-filling station on the instrument. Thus, the increase in sample throughout is not limited to electrophoresis time, but all steps of gel preparation and sample loading. Use of 4-color chemistries has been used in DNA sequencing and permits detection of multiple genetic markers with overlapping size ranges. Multiplexing strategies increase sample throughput and conserve reagent costs when done during the PCR amplification step.
Estimated time from capillary filling, sample injection, separation and refilling of the capillary for the next run is under 1.5 hours. 138, 139 With continuous operation (16 runs per day), 1536 samples could be processed per day by CAE. By using the 4-color multiplex strategy that has been applied to slab-gel electrophoresis systems, 27 648 genotypes could be determined per day (1536 samples ϫ 3 colors of labels ϫ 6 loci/color) compared to a maximum of 4 runs in 24 hours on current slab-gel systems. The CAE approach translates into 2304 genotype analyses per day (128 samples ϫ 3 colors of labels ϫ 6 loci/color). Thus, CAE systems would have a ten-fold greater throughput and require much less hands-on time for operation.
Conclusions
We have witnessed the initial impact of parallel molecular genetic analysis, increasing sample throughput and facilitating semi-automated data analysis. More importantly, these new technologies, such as DNA microarrays and capillary array electrophoresis, replace standard molecular biology platforms and may lead to further technological advances in genetic analysis. In addition, recent developments in scanner technology promise to reduce the time needed to obtain large amounts of information at the same time.
Some specific comparative strengths and weaknesses of analytic technologies for mutation detection and gene expression profiling have been listed in the individual sections. Here we summarize a framework for decision making in selecting available technology options, which is tabulated in Table 1 for seven of the most common molecular genetic tasks. Our philosophy is to list the technology options for which there is a body of literature and to identify the criteria for 1 Tasks range from allele-specific to genome-wide; additional uses in research and development include forensic identification, pathogen identification, microsatellite instability analysis and DNA methylation analysis. 2 References based primarily on the peer-reviewed literature up to 01/31/1998. 3 End users include biomedical research laboratories, molecular diagnostic clinical laboratories and the pharmaceutical industry.
Parallel Molecular Genetic Analysis t selection by end users. The literature in this area is exploding rapidly, and our tabulation is as of 30 January 1998. Updates will clearly be needed in the future, and other recent reviews offer alternative opinions. 52, [140] [141] [142] [143] The technology option which is best will be driven by different criteria for different users. The relative importance of upfront and ongoing operational costs and how adaptable and generalizable a technology is will depend on whether one is in an academic biomedical research center, a clinical molecular diagnostics laboratory or the pharmaceutical industry, among other venues. By generalizable we mean able to be used by any laboratory with current molecular genetics expertise. By adaptable we mean able to be used for new genes or by multiple users with different interests. In first generation DNA microarray technology, the upfront costs for an arrayer and a scanner system are of the order of $200 000-250 000. Chip costs vary between premade and marketed and making one's own. High volume use keeps the per chip cost low, and then operator time and sample preparation become significant ongoing operational costs. Capillary array electrophoresis units are expected to cost under $200 000 initially, and operating costs will be comparable to gel-based systems. In summary, in Table 1 we provide a framework by which readers can make their own best decisions. We anticipate that in the future consolidation of function and miniaturization will continue. Consolidation of the functions of sample preparation, target amplification and labelling, real time detection, analysis and informatics will result in very powerful tools. As the Human Genome Initiative meets its objectives, we may find a return to a focus on parallel molecular genetic technologies for specific diseases and conditions, eg all cardiovascular disease susceptibility genetic changes, all molecular alterations present in leukemia, all genetic variations relevant to drug metabolism, etc.
